JP Morgan 2023 - Stefan Weber and Ravi Anand
R&D
In San Francisco in January for JP Morgan, editor-in-chief Jonah Comstock sat down at the Hotel Spero with Stefan Weber and Ravi Anand, CEO and CMO, respectively, of neurology-focused biotech Newron.
Newron (which just today published some promising phase 2 results) is focused on novel therapies for patients with diseases of the central and peripheral nervous system. Jonah and the Newron team discuss the company’s drug Evenamide, which has had strong performance in patients with treatment-resistant schizophrenia.
They also talk about the neuro space more broadly and why it’s poised to be such an important segment in 2023.
Check out the video below to learn more about an exciting new treatment area and for some insights into the R&D trends.
